The advantages and disadvantages of home hemodialysis

Hemodialysis International

Volumn 12, Issue SUPPL. 1, 2008, Pages

  Masterson, Rosemary ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cardiovascular outcomes; Extendedhours dialysis; Home hemodialysis; Nocturnal hemodialysis; Qualityof life

Indexed keywords

ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CAREGIVER BURDEN; EXERCISE; HEALTH ECONOMICS; HOME DIALYSIS; HUMAN; INSOMNIA; KIDNEY FAILURE; PATIENT ATTITUDE; PATIENT EDUCATION; PHOSPHATE BALANCE; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SELF CARE; SLEEP APNEA SYNDROME; SOCIAL LIFE; SOCIAL PSYCHOLOGY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; WORK RESUMPTION;

CARDIOVASCULAR DISEASES; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RISK FACTORS;

EID: 47649122263     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00290.x     Document Type: Article

References (36)

1. Australia and New Zealand Dialysis and Transplant Registry. ANZDATA Registry Report 2006. Adelaide, South Australia, 2007.
2. Mailloux LU, Kapikian N, Napolitano B, et al. Home hemodialysis: Patient outcomes during a 24-year period of time from 1970 through 1993. Adv Ren Replace Ther. 1996; 3: 112-119.
3. McGregor DO, Buttimore AL, Lynn KL. Home hemodialysis: Excellent survival at less cost, but still underutilized. Kidney Int. 2000; 57: 2654-2655.
4. Woods JD, Port FK, Stannard D, Blagg CR, Held PJ. Comparison of mortality with home hemodialysis and center hemodialysis: A national study. Kidney Int. 1996; 49: 1464-1470.
5. Saner E, Nitsch D, Descoeudres C, Frey FJ, Uehlinger DE. Outcome of home haemodialysis patients: A case-cohort study. Nephrol Dial Transplant. 2005; 20: 604-610.
6. Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol. 1996; 16: 35-44.
7. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA. 1991; 265: 871-875.
8. Australia and New Zealand Dialysis and Transplant Registry. ANZDATA Registry Report 2005. Adelaide, South Australia, 2006.
9. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008; 51 (Suppl 1): S1-S320.
10. Foley R, Parfrey P, Samak M. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32 (Suppl 3): S112-S119.
11. Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol. 1998; 9: 859-868.
12. Bergman A, Fenton SS, Richardson RM, Chan CT. Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol. 2008; 69: 33-39.
13. Pauly RP, Chan CT. Reversing the risk factor paradox: Is daily nocturnal hemodialysis the solution? Semin Dial. 2007; 20: 539-543.
14. Chan CT, Jain V, Picton P, Pierratos A, Floras JS. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int. 2005; 68: 338-344.
15. Fagugli RM, Pasini P, Pasticci F, Ciao G, Cicconi B, Buoncristiani U. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: A comparative study. J Nephrol. 2006; 19: 77-83.
16. Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA. 2007; 298: 1291-1299.
17. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006; 70: 351-357.
18. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis. 2000; 35: 1226-1237.
19. Toussaint N, Boddington J, Simmonds R, Waldron C, Somerville C, Agar J. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial Int. 2006; 10: 280-286.
20. Van Eps C, Jeffries J, Anderson JA, et al. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology. 2007; 12: 224-233.
21. Kooienga L. Phosphorus balance with daily dialysis. Semin Dial. 2007; 20: 342-345.
22. Yuen D, Pierratos A, Richardson RM, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant. 2006; 21: 1407-1412.
23. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99: 2434-2439.
24. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007; 18: 613-620.
25. Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P. Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension. 2007; 49: 1278-1284.
26. Lian M, Masterson R, Perkovic V, Becker GJ. The role of nocturnal haemodialysis and arterial stiffness. Am Soc Nephrol. 2006; 17: FC102.
27. Hanly P, Chan C, Pierratos A. The impact of nocturnal hemodialysis on sleep apnea in ESRD patients. Nephrol News Issues. 2003; 17: 19-21.
28. Chan CT, Notarius CF, Merlocco AC, Floras JS. Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant. 2007; 22: 3285-3291.
29. Evans RW, Manninen DL, Garrison LP, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985; 312: 553-559.
30. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: A reexamination. Am J Kidney Dis. 1989; 13: 200-209.
31. Oberley ET, Schatell DR. Home hemodialysis: Survival, quality of life, and rehabilitation. Adv Ren Replace Ther. 1996; 3: 147-153.
32. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005; 67: 1500-1508.
33. Agar JW. Nocturnal haemodialysis in Australia and New Zealand. Nephrology (Carlton). 2005; 10: 222-230.
34. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: A decision analysis. Kidney Int. 2006; 69: 798-805.
35. Agar JW, Knight RJ, Simmonds RE, Boddington JM, Waldron CM, Somerville CA. Nocturnal haemodialysis: An Australian cost comparison with conventional satellite haemodialysis. Nephrology (Carlton). 2005; 10: 557-570.
36. Brunier GM, McKeever PT. The impact of home dialysis on the family: Literature review. ANNA J. 1993; 20: 653-659.